Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test 1T Quadruple Marker- AutoDELFIA (LifeCycle) Test is 7 days.

What are the prerequisites for the test 1T Quadruple Marker- AutoDELFIA (LifeCycle) Test

  • Patient must be pregnant
  • Patient must be at least 15 years old
  • Patient must have a valid prescription from a healthcare provider
  • Patient must not have any contraindications to the test

What are the measure values for the test 1T Quadruple Marker- AutoDELFIA (LifeCycle) Test

  • AFP (Alpha-fetoprotein): 0-2.5 MoM
  • uE3 (Unconjugated Estriol): 0-2.5 MoM
  • HCG (Human Chorionic Gonadotropin): 0-2.5 MoM
  • AFP uE3 HCG Inhibin-A: 0-2.5 MoM

What does this test 1T Quadruple Marker- AutoDELFIA (LifeCycle) Test identify?

  • Test Name: 1T Quadruple Marker- AutoDELFIA (LifeCycle) Test
  • Identifies:
    • Alpha-fetoprotein (AFP): A protein produced by the fetus that can indicate neural tube defects, chromosomal abnormalities, or multiple pregnancies.
    • Human chorionic gonadotropin (hCG): A hormone produced by the placenta that can indicate pregnancy or certain types of cancer.
    • Unconjugated estriol (uE3): A hormone produced by the placenta that can indicate chromosomal abnormalities or fetal well-being.
    • Inhibin A: A protein produced by the placenta that can indicate certain types of chromosomal abnormalities.

Why is this test 1T Quadruple Marker- AutoDELFIA (LifeCycle) Test taken?

Test Name:

1T Quadruple Marker- AutoDELFIA (LifeCycle) Test

Reason for Test:

The 1T Quadruple Marker- AutoDELFIA (LifeCycle) Test is taken to screen for certain genetic conditions and abnormalities in the developing fetus. This test is typically recommended for pregnant women between 15 to 20 weeks of gestation. The test helps in detecting any potential risks of chromosomal abnormalities, neural tube defects, and genetic disorders in the fetus. It can also provide information about the baby's growth and development. Overall, the test is important in assessing the health and well-being of both the mother and the baby during pregnancy.

No FAQs available.

Customer Google Rating